Background illustration for clinical trials search

Paid Clinical Trials Fort Collins

Discover 1,283 paid clinical trials in Fort Collins, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

for
Pulmonary Hypertension Due to Lung Disease (Disorder)
Location: Denver CO, Aurora CO, Scottsdale AZ, Phoenix AZ,
Sponsor: Liquidia Technologies, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07285655

Phase 3, Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for
Carcinoma, Non-Small-Cell Lung
Location: Denver CO, Springdale AR, Cedar Rapids IA, Dallas TX,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06875310

Phase 3, Recruiting

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Denver CO, Salt Lake City UT, Kansas City KS,
Sponsor: Rein Therapeutics

Sex: All

Age: 40+

Code: NCT06968845

Phase 2, Recruiting

Study With Phage for CF Subjects With Pseudomonas Lung Infection

for
Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)
Location: Denver CO, San Francisco CA, Nashville TN,
Sponsor: BiomX Ltd

Sex: All

Age: 18+

Code: NCT06998043

Phase 2, Recruiting

Deployment-Related Lung Disease Research Database and Biorepository

for
Bronchiolitis
Location: Denver CO
Sponsor: National Jewish Health

Sex: All

Age: 18+

Code: NCT03035097

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

for
Ototoxicity, Drug-Induced
Location: Denver CO, Tyler TX, Portland OR, San Francisco CA,
Sponsor: Kevin Winthrop

Sex: All

Age: 18 - 70+

Code: NCT05730283

Phase 2, Recruiting

Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

for
Asthma
Location: Denver CO
Sponsor: National Jewish Health

Sex: All

Age: 18+

Code: NCT02947945

Phase 2, Recruiting

Measuring Omalizumab Responses Using Real-world Evidence (MORRE) Study

for
Asthma
Location: Denver CO
Sponsor: National Jewish Health

Sex: All

Age: 18 - 70+

Code: NCT04724278

Recruiting

Interstitial Lung Disease in Early Rheumatoid Arthritis

for
Rheumatoid Arthritis, Interstitial Lung Disease
Location: Denver CO
Sponsor: National Jewish Health

Sex: All

Age: 18 - 70+

Code: NCT03977415

Recruiting

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

for
Cystic Fibrosis
Location: Denver CO, Aurora CO, Salt Lake City UT, Billings MT,
Sponsor: Nicole Hamblett

Sex: All

Age: 12+

Code: NCT06504589

Recruiting

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

for
Systemic Sclerosis Associated Interstitial Lung Disease,
Location: Aurora CO, El Paso TX, Scottsdale AZ, Tucson AZ,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05878717

Phase 2, Phase 3, Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

for
Melanoma, Lymphoma, Solid Tumor, Classical Hodgkin Lymphoma,
Location: Aurora CO, Sioux Falls SD, Fargo ND, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT02332668

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus
Location: Aurora CO, Oklahoma City OK, Kansas City KS,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 16+

Code: NCT06617325

Phase 3, Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Aurora CO, Omaha NE, Kansas City MO, Columbia MO,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase 2, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

for
Neoplasms, Colorectal, Neoplasms
Location: Aurora CO, Nashville TN, Detroit MI, Canton OH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07213609

Phase 1, Phase 2, Recruiting

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

for
Eosinophilic Asthma
Location: Aurora CO, Edmond OK, Kansas City KS, McKinney TX,
Sponsor: Kymera Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07323654

Phase 2, Recruiting

Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

for
Higher-risk Myelodysplastic Syndrome
Location: Aurora CO, Lincoln NE, Phoenix AZ, Minneapolis MN,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06641414

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis

for
Amyloidosis
Location: Aurora CO, Salt Lake City UT, Rochester MN,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07224672

Phase 2, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

for
Hypoxic-Ischemic Encephalopathy
Location: Aurora CO, Fort Worth TX, St Louis MO, Little Rock AR,
Sponsor: ReAlta Life Sciences, Inc.

Sex: All

Age: 0

Code: NCT05778188

Phase 2, Phase 3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Aurora CO, Golden CO, Hutchinson KS, Wichita KS,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting